Pharma Mar S.A. Logo

Pharma Mar S.A.

Biopharmaceutical company developing oncology treatments from marine sources.

PHM | MC

Overview

Corporate Details

ISIN(s):
ES0169501022 (+1 more)
LEI:
959800QWKZ45ZQC2AV58
Country:
Spain
Address:
Avenida de los Reyes 1 Polígono Industrial La Mina, 28770 Colmenar Viejo

Description

Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-02-27 00:00 English 5.5 MB
2020-02-26 19:58
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 236.8 KB
2020-02-26 00:00
Corporate Governance Report - Pharma Mar S.A.
Spanish 236.8 KB
2020-02-17 08:28
Pharma Mar informa que la FDA ha aceptado y concedido la revisión prioritaria a…
Spanish 130.6 KB
2019-03-01 00:00 Spanish 13.1 MB
2019-02-28 00:00
Corporate Governance Report - Pharma Mar S.A.
Spanish 235.3 KB
2019-01-02 14:40
Pelican House Mining Plc - Outcome of General Meeting
English 10.9 KB
2018-12-12 16:30
Pelican House Mining Plc - Dealing by ex- Director; Notifiable Interest
English 10.4 KB
2018-12-11 13:00
Pelican House Mining Plc - Dealing by ex- Director; Notifiable Interest
English 10.3 KB
2018-12-10 18:21
Pelican House Mining Plc - Posting of Circular and General Meeting Notice
English 21.5 KB
2018-12-06 18:09
Pelican House Mining Plc - Change of Strategy; Conditional Issue of Equity
English 12.7 KB
2018-12-05 11:51
Pelican House Mining Plc - Directorate Changes
English 12.0 KB
2018-10-05 09:00
Pelican House Mining Plc - Director's Dealing in Shares
English 8.8 KB
2018-08-06 11:27
Pelican House Mining Plc - Investment Update
English 10.1 KB
2018-07-12 09:00
Pelican House Mining Plc - Half-year Report and Interim Financial Statements
English 106.2 KB

Automate Your Workflow. Get a real-time feed of all Pharma Mar S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharma Mar S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharma Mar S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.